SCHEMBL22108474

SCHEMBL22108474

CC(=O)Nc1ccc(-c2coc3c4c(c(CC=C(C)C)c(O)c3c2=O)OC(C)(C)C=C4)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.81
CYP3A4 P08684 6/20 0.81
MAPT P10636 5/20 0.81
MAPK1 P28482 3/20 0.81
ALDH1A1 P00352 3/20 0.81
MEN1 O00255 3/20 0.81
USP2 O75604 3/20 0.81
ALOX15 P16050 3/20 0.81
KMT2A Q03164 3/20 0.81
HDAC3 O15379 2/20 0.81
TP53 P04637 2/20 0.81
HDAC4 P56524 2/20 0.81
HDAC1 Q13547 2/20 0.81
SMN1; SMN2 Q16637 2/20 0.81
HDAC7 Q8WUI4 2/20 0.81
HDAC2 Q92769 2/20 0.81
HDAC10 Q969S8 2/20 0.81
HDAC11 Q96DB2 2/20 0.81
HDAC8 Q9BY41 2/20 0.81
HDAC6 Q9UBN7 2/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22108483 0.93 PTPN1 (0.77) PTPN1CYP3A4MAPTMAPK1ALDH1A1
SCHEMBL22108479 0.93 PTPN1 (0.77) PTPN1CYP3A4MAPTMAPK1ALDH1A1
SCHEMBL24305361 0.92 PTPN1 (0.76) PTPN1CYP3A4MAPTMAPK1ALDH1A1
Osajin SCHEMBL571689 0.90 PTPN1 (1.00) PTPN1CYP3A4MAPTMAPK1ALDH1A1
SCHEMBL18906967 0.89 PTPN1 (0.88) PTPN1CYP3A4MAPTMAPK1ALDH1A1
Osajin SCHEMBL22093541 0.87 PTPN1 (0.95) PTPN1CYP3A4MAPTMAPK1ALDH1A1
SCHEMBL11911697 0.86 CYP3A4 (0.84) PTPN1CYP3A4MAPTMAPK1ALDH1A1
Osajin SCHEMBL27659828 0.86 PTPN1 (0.93) PTPN1CYP3A4MAPTMAPK1ALDH1A1
SCHEMBL22108481 0.86 PTPN1 (0.60) PTPN1CYP3A4MAPTMAPK1ALDH1A1
Pomiferin SCHEMBL8059171 0.85 CYP3A4 (1.00) PTPN1CYP3A4MAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119399-A1 COMPOUNDS AND COMPOSITIONS THAT CAUSE MYCN AND/OR CMYC DEGRADATION AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2022-04-21 US disclosed
WO-2020123699-A1 COMPOUNDS AND COMPOSITIONS THAT CAUSE MYCN AND/OR CMYC DEGRADATION AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119399-A1 COMPOUNDS AND COMPOSITIONS THAT CAUSE MYCN AND/OR CMYC DEGRADATION AND METHODS OF USE THEREOF MYC, MYCBP, MYCBP2 PTPN1 2016/4885CYP3A4 4830/4885MAPT 1899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.